Global Oncology (Anti-cancer Drugs) Market Insights and Forecast to 2028

Global Oncology (Anti-cancer Drugs) Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Oncology (Anti-cancer Drugs) Product Introduction
1.2 Market by Type
1.2.1 Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Cancer
1.2.3 Breast Cancer
1.2.4 Gastrointestinal Cancer
1.2.5 Prostate Cancer
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy (Biologic Therapy)
1.3.5 Hormonal Therapy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology (Anti-cancer Drugs) Sales Estimates and Forecasts 2017-2028
2.2 Global Oncology (Anti-cancer Drugs) Revenue Estimates and Forecasts 2017-2028
2.3 Global Oncology (Anti-cancer Drugs) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oncology (Anti-cancer Drugs) Sales by Region
2.4.1 Global Oncology (Anti-cancer Drugs) Sales by Region (2017-2022)
2.4.2 Global Sales Oncology (Anti-cancer Drugs) by Region (2023-2028)
2.5 Global Oncology (Anti-cancer Drugs) Revenue by Region
2.5.1 Global Oncology (Anti-cancer Drugs) Revenue by Region (2017-2022)
2.5.2 Global Oncology (Anti-cancer Drugs) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oncology (Anti-cancer Drugs) Sales by Manufacturers
3.1.1 Global Top Oncology (Anti-cancer Drugs) Manufacturers by Sales (2017-2022)
3.1.2 Global Oncology (Anti-cancer Drugs) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology (Anti-cancer Drugs) in 2021
3.2 Global Oncology (Anti-cancer Drugs) Revenue by Manufacturers
3.2.1 Global Oncology (Anti-cancer Drugs) Revenue by Manufacturers (2017-2022)
3.2.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oncology (Anti-cancer Drugs) Revenue in 2021
3.3 Global Oncology (Anti-cancer Drugs) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oncology (Anti-cancer Drugs) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oncology (Anti-cancer Drugs) Sales by Type
4.1.1 Global Oncology (Anti-cancer Drugs) Historical Sales by Type (2017-2022)
4.1.2 Global Oncology (Anti-cancer Drugs) Forecasted Sales by Type (2023-2028)
4.1.3 Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2017-2028)
4.2 Global Oncology (Anti-cancer Drugs) Revenue by Type
4.2.1 Global Oncology (Anti-cancer Drugs) Historical Revenue by Type (2017-2022)
4.2.2 Global Oncology (Anti-cancer Drugs) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2017-2028)
4.3 Global Oncology (Anti-cancer Drugs) Price by Type
4.3.1 Global Oncology (Anti-cancer Drugs) Price by Type (2017-2022)
4.3.2 Global Oncology (Anti-cancer Drugs) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oncology (Anti-cancer Drugs) Sales by Application
5.1.1 Global Oncology (Anti-cancer Drugs) Historical Sales by Application (2017-2022)
5.1.2 Global Oncology (Anti-cancer Drugs) Forecasted Sales by Application (2023-2028)
5.1.3 Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2017-2028)
5.2 Global Oncology (Anti-cancer Drugs) Revenue by Application
5.2.1 Global Oncology (Anti-cancer Drugs) Historical Revenue by Application (2017-2022)
5.2.2 Global Oncology (Anti-cancer Drugs) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2017-2028)
5.3 Global Oncology (Anti-cancer Drugs) Price by Application
5.3.1 Global Oncology (Anti-cancer Drugs) Price by Application (2017-2022)
5.3.2 Global Oncology (Anti-cancer Drugs) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oncology (Anti-cancer Drugs) Market Size by Type
6.1.1 North America Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
6.1.2 North America Oncology (Anti-cancer Drugs) Revenue by Type (2017-2028)
6.2 North America Oncology (Anti-cancer Drugs) Market Size by Application
6.2.1 North America Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
6.2.2 North America Oncology (Anti-cancer Drugs) Revenue by Application (2017-2028)
6.3 North America Oncology (Anti-cancer Drugs) Market Size by Country
6.3.1 North America Oncology (Anti-cancer Drugs) Sales by Country (2017-2028)
6.3.2 North America Oncology (Anti-cancer Drugs) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oncology (Anti-cancer Drugs) Market Size by Type
7.1.1 Europe Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
7.1.2 Europe Oncology (Anti-cancer Drugs) Revenue by Type (2017-2028)
7.2 Europe Oncology (Anti-cancer Drugs) Market Size by Application
7.2.1 Europe Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
7.2.2 Europe Oncology (Anti-cancer Drugs) Revenue by Application (2017-2028)
7.3 Europe Oncology (Anti-cancer Drugs) Market Size by Country
7.3.1 Europe Oncology (Anti-cancer Drugs) Sales by Country (2017-2028)
7.3.2 Europe Oncology (Anti-cancer Drugs) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oncology (Anti-cancer Drugs) Market Size by Type
8.1.1 Asia Pacific Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
8.1.2 Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Type (2017-2028)
8.2 Asia Pacific Oncology (Anti-cancer Drugs) Market Size by Application
8.2.1 Asia Pacific Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
8.2.2 Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Application (2017-2028)
8.3 Asia Pacific Oncology (Anti-cancer Drugs) Market Size by Region
8.3.1 Asia Pacific Oncology (Anti-cancer Drugs) Sales by Region (2017-2028)
8.3.2 Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oncology (Anti-cancer Drugs) Market Size by Type
9.1.1 Latin America Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
9.1.2 Latin America Oncology (Anti-cancer Drugs) Revenue by Type (2017-2028)
9.2 Latin America Oncology (Anti-cancer Drugs) Market Size by Application
9.2.1 Latin America Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
9.2.2 Latin America Oncology (Anti-cancer Drugs) Revenue by Application (2017-2028)
9.3 Latin America Oncology (Anti-cancer Drugs) Market Size by Country
9.3.1 Latin America Oncology (Anti-cancer Drugs) Sales by Country (2017-2028)
9.3.2 Latin America Oncology (Anti-cancer Drugs) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oncology (Anti-cancer Drugs) Market Size by Type
10.1.1 Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Type (2017-2028)
10.2 Middle East and Africa Oncology (Anti-cancer Drugs) Market Size by Application
10.2.1 Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Application (2017-2028)
10.3 Middle East and Africa Oncology (Anti-cancer Drugs) Market Size by Country
10.3.1 Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Celgene
11.3.1 Celgene Corporation Information
11.3.2 Celgene Overview
11.3.3 Celgene Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Celgene Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celgene Recent Developments
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Overview
11.4.3 Amgen Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Amgen Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 Eli lilly & Co
11.7.1 Eli lilly & Co Corporation Information
11.7.2 Eli lilly & Co Overview
11.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eli lilly & Co Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eli lilly & Co Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Merck & Co.
11.9.1 Merck & Co. Corporation Information
11.9.2 Merck & Co. Overview
11.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merck & Co. Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck & Co. Recent Developments
11.10 Sanofi
11.10.1 Sanofi Corporation Information
11.10.2 Sanofi Overview
11.10.3 Sanofi Oncology (Anti-cancer Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sanofi Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oncology (Anti-cancer Drugs) Industry Chain Analysis
12.2 Oncology (Anti-cancer Drugs) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology (Anti-cancer Drugs) Production Mode & Process
12.4 Oncology (Anti-cancer Drugs) Sales and Marketing
12.4.1 Oncology (Anti-cancer Drugs) Sales Channels
12.4.2 Oncology (Anti-cancer Drugs) Distributors
12.5 Oncology (Anti-cancer Drugs) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oncology (Anti-cancer Drugs) Industry Trends
13.2 Oncology (Anti-cancer Drugs) Market Drivers
13.3 Oncology (Anti-cancer Drugs) Market Challenges
13.4 Oncology (Anti-cancer Drugs) Market Restraints
14 Key Findings in The Global Oncology (Anti-cancer Drugs) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Blood Cancer
Table 3. Major Manufacturers of Breast Cancer
Table 4. Major Manufacturers of Gastrointestinal Cancer
Table 5. Major Manufacturers of Prostate Cancer
Table 6. Major Manufacturers of Others
Table 7. Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Oncology (Anti-cancer Drugs) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Oncology (Anti-cancer Drugs) Sales by Region (2017-2022) & (K MT)
Table 10. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2017-2022)
Table 11. Global Oncology (Anti-cancer Drugs) Sales by Region (2023-2028) & (K MT)
Table 12. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2023-2028)
Table 13. Global Oncology (Anti-cancer Drugs) Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2017-2022)
Table 15. Global Oncology (Anti-cancer Drugs) Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2023-2028)
Table 17. Global Oncology (Anti-cancer Drugs) Sales by Manufacturers (2017-2022) & (K MT)
Table 18. Global Oncology (Anti-cancer Drugs) Sales Share by Manufacturers (2017-2022)
Table 19. Global Oncology (Anti-cancer Drugs) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Oncology (Anti-cancer Drugs) Revenue Share by Manufacturers (2017-2022)
Table 21. Oncology (Anti-cancer Drugs) Price by Manufacturers (2017-2022) &(USD/MT)
Table 22. Global Oncology (Anti-cancer Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Oncology (Anti-cancer Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2021)
Table 24. Oncology (Anti-cancer Drugs) Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Oncology (Anti-cancer Drugs) Product Offered
Table 26. Date of Manufacturers Enter into Oncology (Anti-cancer Drugs) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 29. Global Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 30. Global Oncology (Anti-cancer Drugs) Sales Share by Type (2017-2022)
Table 31. Global Oncology (Anti-cancer Drugs) Sales Share by Type (2023-2028)
Table 32. Global Oncology (Anti-cancer Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Oncology (Anti-cancer Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Oncology (Anti-cancer Drugs) Revenue Share by Type (2017-2022)
Table 35. Global Oncology (Anti-cancer Drugs) Revenue Share by Type (2023-2028)
Table 36. Oncology (Anti-cancer Drugs) Price by Type (2017-2022) & (USD/MT)
Table 37. Global Oncology (Anti-cancer Drugs) Price Forecast by Type (2023-2028) & (USD/MT)
Table 38. Global Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 39. Global Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 40. Global Oncology (Anti-cancer Drugs) Sales Share by Application (2017-2022)
Table 41. Global Oncology (Anti-cancer Drugs) Sales Share by Application (2023-2028)
Table 42. Global Oncology (Anti-cancer Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Oncology (Anti-cancer Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Oncology (Anti-cancer Drugs) Revenue Share by Application (2017-2022)
Table 45. Global Oncology (Anti-cancer Drugs) Revenue Share by Application (2023-2028)
Table 46. Oncology (Anti-cancer Drugs) Price by Application (2017-2022) & (USD/MT)
Table 47. Global Oncology (Anti-cancer Drugs) Price Forecast by Application (2023-2028) & (USD/MT)
Table 48. North America Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 49. North America Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 50. North America Oncology (Anti-cancer Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Oncology (Anti-cancer Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 53. North America Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 54. North America Oncology (Anti-cancer Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Oncology (Anti-cancer Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Oncology (Anti-cancer Drugs) Sales by Country (2017-2022) & (K MT)
Table 57. North America Oncology (Anti-cancer Drugs) Sales by Country (2023-2028) & (K MT)
Table 58. North America Oncology (Anti-cancer Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Oncology (Anti-cancer Drugs) Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 61. Europe Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 62. Europe Oncology (Anti-cancer Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Oncology (Anti-cancer Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 65. Europe Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 66. Europe Oncology (Anti-cancer Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Oncology (Anti-cancer Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Oncology (Anti-cancer Drugs) Sales by Country (2017-2022) & (K MT)
Table 69. Europe Oncology (Anti-cancer Drugs) Sales by Country (2023-2028) & (K MT)
Table 70. Europe Oncology (Anti-cancer Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Oncology (Anti-cancer Drugs) Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 73. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 74. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 77. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 78. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Region (2017-2022) & (K MT)
Table 81. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Region (2023-2028) & (K MT)
Table 82. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 85. Latin America Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 86. Latin America Oncology (Anti-cancer Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Oncology (Anti-cancer Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 89. Latin America Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 90. Latin America Oncology (Anti-cancer Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Oncology (Anti-cancer Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2017-2022) & (K MT)
Table 93. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2023-2028) & (K MT)
Table 94. Latin America Oncology (Anti-cancer Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Oncology (Anti-cancer Drugs) Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Type (2017-2022) & (K MT)
Table 97. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Type (2023-2028) & (K MT)
Table 98. Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Application (2017-2022) & (K MT)
Table 101. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Application (2023-2028) & (K MT)
Table 102. Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2017-2022) & (K MT)
Table 105. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2023-2028) & (K MT)
Table 106. Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Country (2023-2028) & (US$ Million)
Table 108. Roche Corporation Information
Table 109. Roche Description and Major Businesses
Table 110. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 111. Roche Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Roche Recent Developments
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Major Businesses
Table 115. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 116. Novartis Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Novartis Recent Developments
Table 118. Celgene Corporation Information
Table 119. Celgene Description and Major Businesses
Table 120. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 121. Celgene Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Celgene Recent Developments
Table 123. Amgen Corporation Information
Table 124. Amgen Description and Major Businesses
Table 125. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 126. Amgen Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Amgen Recent Developments
Table 128. Johnson & Johnson Corporation Information
Table 129. Johnson & Johnson Description and Major Businesses
Table 130. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 131. Johnson & Johnson Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Johnson & Johnson Recent Developments
Table 133. GlaxoSmithKline Corporation Information
Table 134. GlaxoSmithKline Description and Major Businesses
Table 135. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 136. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. GlaxoSmithKline Recent Developments
Table 138. Eli lilly & Co Corporation Information
Table 139. Eli lilly & Co Description and Major Businesses
Table 140. Eli lilly & Co Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 141. Eli lilly & Co Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Eli lilly & Co Recent Developments
Table 143. Pfizer Corporation Information
Table 144. Pfizer Description and Major Businesses
Table 145. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 146. Pfizer Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Pfizer Recent Developments
Table 148. Merck & Co. Corporation Information
Table 149. Merck & Co. Description and Major Businesses
Table 150. Merck & Co. Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 151. Merck & Co. Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Merck & Co. Recent Developments
Table 153. Sanofi Corporation Information
Table 154. Sanofi Description and Major Businesses
Table 155. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 156. Sanofi Oncology (Anti-cancer Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Sanofi Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Oncology (Anti-cancer Drugs) Distributors List
Table 161. Oncology (Anti-cancer Drugs) Customers List
Table 162. Oncology (Anti-cancer Drugs) Market Trends
Table 163. Oncology (Anti-cancer Drugs) Market Drivers
Table 164. Oncology (Anti-cancer Drugs) Market Challenges
Table 165. Oncology (Anti-cancer Drugs) Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology (Anti-cancer Drugs) Product Picture
Figure 3. Global Oncology (Anti-cancer Drugs) Market Share by Type in 2021 & 2028
Figure 3. Blood Cancer Product Picture
Figure 4. Breast Cancer Product Picture
Figure 5. Gastrointestinal Cancer Product Picture
Figure 6. Prostate Cancer Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oncology (Anti-cancer Drugs) Market Share by Application in 2021 & 2028
Figure 9. Chemotherapy
Figure 10. Targeted Therapy
Figure 11. Immunotherapy (Biologic Therapy)
Figure 12. Hormonal Therapy
Figure 13. Others
Figure 14. Oncology (Anti-cancer Drugs) Report Years Considered
Figure 15. Global Oncology (Anti-cancer Drugs) Sales 2017-2028 (K MT)
Figure 16. Global Oncology (Anti-cancer Drugs) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Oncology (Anti-cancer Drugs) Revenue 2017-2028 (US$ Million)
Figure 18. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2017-2022)
Figure 20. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2023-2028)
Figure 21. North America Oncology (Anti-cancer Drugs) Sales YoY (2017-2028) & (K MT)
Figure 22. North America Oncology (Anti-cancer Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Oncology (Anti-cancer Drugs) Sales YoY (2017-2028) & (K MT)
Figure 24. Europe Oncology (Anti-cancer Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Oncology (Anti-cancer Drugs) Sales YoY (2017-2028) & (K MT)
Figure 26. Asia-Pacific Oncology (Anti-cancer Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Oncology (Anti-cancer Drugs) Sales YoY (2017-2028) & (K MT)
Figure 28. Latin America Oncology (Anti-cancer Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Oncology (Anti-cancer Drugs) Sales YoY (2017-2028) & (K MT)
Figure 30. Middle East & Africa Oncology (Anti-cancer Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Oncology (Anti-cancer Drugs) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Oncology (Anti-cancer Drugs) in the World: Market Share by Oncology (Anti-cancer Drugs) Revenue in 2021
Figure 33. Global Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2017-2028)
Figure 35. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2017-2028)
Figure 36. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2017-2028)
Figure 37. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2017-2028)
Figure 38. North America Oncology (Anti-cancer Drugs) Sales Market Share by Type (2017-2028)
Figure 39. North America Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2017-2028)
Figure 40. North America Oncology (Anti-cancer Drugs) Sales Market Share by Application (2017-2028)
Figure 41. North America Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2017-2028)
Figure 42. North America Oncology (Anti-cancer Drugs) Sales Share by Country (2017-2028)
Figure 43. North America Oncology (Anti-cancer Drugs) Revenue Share by Country (2017-2028)
Figure 44. U.S. Oncology (Anti-cancer Drugs) Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Oncology (Anti-cancer Drugs) Revenue (2017-2028

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs